198
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Excellent very early neointimal coverage of bioactive stents by optical coherence tomography

&
Pages 280-285 | Received 12 Jun 2015, Accepted 07 Jul 2015, Published online: 28 Jul 2015

References

  • Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435–41.
  • Murata A, Wallace-Bradley D, Tellez A, Alviar C, Aboodi M, Sheehy A, et al. Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation. JACC Cardiovasc Imaging. 2010;3:76–84.
  • Templin C, Meyer M, Muller MF, Djonov V, Hlushchuk R, Dimova I, et al. Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. Eur Heart J. 2010;31: 1792–801.
  • Nammas W, Ligthart JM, Karanasos A, Witberg KT, Regar E. Optical coherence tomography for evaluation of coronary stents in vivo. Expert Rev Cardiovasc Ther. 2013; 11:577–88.
  • Mosseri M, Miller H, Tamari I, Plich M, Hasin Y, Brizines M, et al. The titanium-NO stent: results of a multicenter registry. Eurointervention. 2006;2:192–6.
  • Karjalainen PP, Ylitalo A, Airaksinen KEJ, Nammas W. Five-year clinical outcome of titanium nitride-oxide-coated bioactive stent implantation in a real world population: A comparison with paclitaxel-eluting stents: The PORI registry. J Interv Cardiol. 2011;24:1–8.
  • Tuomainen PO, Ylitalo A, Niemelä M, Kervinen K, Pietilä M, Sia J, et al. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: Long-term follow-up from the TITAX AMI trial. Int J Cardiol. 2013; 168:1214–9.
  • Karjalainen PP, Niemelä M, Airaksinen JK, Rivero-Crespo F, Romppanen H, Sia J, et al. A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial. EuroIntervention. 2012;8:306–15.
  • Romppanen H, Nammas W, Kervinen K, Airaksinen JK, Pietilä M, Rivero-Crespo F, et al. Stent-oriented versus patient-oriented outcome in patients undergoing early percutaneous coronary intervention for acute coronary syndrome: 2-year report from the BASE-ACS trial. Ann Med. 2013;45:488–93.
  • Annala AP, Lehtinen T, Kiviniemi TO, Ylitalo A, Nammas W, Karjalainen PP. Vascular healing early after titanium-nitride-oxide-coated stent implantation assessed by optical coherence tomography. J Invasive Cardiol. 2013;25:186–9.
  • Karjalainen P, Kiviniemi TO, Lehtinen T, Nammas W, Ylitalo A, Saraste A, et al. Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial. Int J Cardiovasc Imaging. 2013;29:1693–703.
  • Lehtinen T, Nammas W, Airaksinen JK, Karjalainen PP. Feasibility and safety of frequency-domain optical coherence tomography for coronary artery evaluation: a single-center study. Int J Cardiovasc Imaging. 2013;29:997–1005.
  • Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI. Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. JACC Cardiovasc Interv. 2009;2:1035–46.
  • Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation. 2003;108:1701–6.
  • Prati F, Romagnoli E, Valgimigli M, Burzotta F, De Benedictis M, Ramondo A, et al. Randomized comparison between 3-month Cre8 DES vs. 1-month Vision/Multilink8 BMS neointimal coverage assessed by OCT evaluation: the DEMONSTRATE study. Int J Cardiol. 2014;176:904–9.
  • Qian J, Zhang YJ, Xu B, Yang YJ, Yan HB, Sun ZW, et al. Optical coherence tomography assessment of a PLGA- polymer with electro-grafting base layer versus a PLA- polymer sirolimus-eluting stent at three-month follow-up: the BuMA-OCT randomised trial. EuroIntervention. 2014; 10:806–14.
  • Papayannis AC, Cipher D, Banerjee S, Brilakis ES. Optical coherence tomography evaluation of drug-eluting stents: a systematic review. Catheter Cardiovasc Interv. 2013;81: 481–7.
  • Kim JS, Jang IK, Fan C, Kim TH, Kim JS, Park SM, et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial. JACC Cardiovasc Interv. 2009;2:1240–7.
  • Hashikata T, Tojo T, Namba S, Kitasato L, Hashimoto T, Kameda R, et al. Neointimal coverage of zotarolimus-eluting stent at 1, 2, and 3 months’ follow-up: an optical coherence tomography study. Heart Vessels. 2014. [Epub ahead of print]
  • Lehtinen T, Kiviniemi TO, Ylitalo A, Mikkelsson J, Airaksinen JK, Karjalainen PP. Early vascular healing after endothelial progenitor cell capturing stent implantation. J Invasive Cardiol. 2012;24:631–5.
  • Gutiérrez-Chico JL, Wykrzykowska J, Nüesch E, van Geuns RJ, Koch KT, Koolen JJ, et al. Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography. Circ Cardiovasc Interv. 2012;5:20–9.
  • Karjalainen PP, Mikkelsson J, Ylitalo A, Paana T, Nammas W. Mid-term clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: OPTIMAX first-in-man study. Rev Esp Cardiol. 2014;67:958–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.